Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study
about
Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptionsDeficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient miceOsteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse.Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects.Cathepsins: a new culprit behind abdominal aortic aneurysm.Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms.Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study.Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer.Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans.Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease.Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy.
P2860
Q27000373-6910AE0C-CDAC-46A2-B3C9-C187C00DA18CQ30528440-BB3EE6D6-4986-49A6-838E-2C89554DD692Q34550560-77E73568-5E93-432D-B651-7C3B32563AF4Q34635528-CC565311-2360-4FEF-A641-C705F70355A4Q35606010-01927F5A-B821-4778-A3CE-EC5DEC40813AQ35786497-FDEE1C73-B9A4-46C0-8DEF-E9DD3853246AQ36027826-DDB7DA4B-95BF-4E5F-ADC5-BCB297D49D6DQ36599238-1D6F2611-2F4F-4A4F-B40D-8C636C7733BFQ37118040-EC0C6978-742F-4ECA-8970-54D03E793F39Q37317502-E7B7FE77-86FD-4C1C-974A-B6EE0F2BC918Q37653212-47A4DA91-69CA-4314-AD5A-59EA919A193DQ38940277-DE61A45E-AD80-4792-BCAD-9C4F3E80E051Q39385660-581A6588-1ABD-4231-A408-6ACD0F2DF8ECQ47696129-FA41D924-4487-4540-B456-775DDFFD9C59Q47696609-FA3B244B-2B10-4B23-86EF-94D95A3C7E13Q48160325-46F1B98C-0BAF-46E9-9841-FD2E9329F4CC
P2860
Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Plasma cathepsin S and cystati ...... domized population-based study
@ast
Plasma cathepsin S and cystati ...... domized population-based study
@en
type
label
Plasma cathepsin S and cystati ...... domized population-based study
@ast
Plasma cathepsin S and cystati ...... domized population-based study
@en
prefLabel
Plasma cathepsin S and cystati ...... domized population-based study
@ast
Plasma cathepsin S and cystati ...... domized population-based study
@en
P2093
P2860
P1433
P1476
Plasma cathepsin S and cystati ...... domized population-based study
@en
P2093
Bing-Jie Lv
Guo-Ping Shi
Xiang Cheng
P2860
P304
P356
10.1371/JOURNAL.PONE.0041813
P407
P50
P577
2012-07-23T00:00:00Z